SCM Pharma has appointed Qualified Person (QP) Paul Thomas a new director to bolster its senior team’s expertise and support ongoing expansion efforts. Mr. Thomas has more than 25 years of sterile manufacturing, technical and commercial experience and held positions with Warner Lambert, Penn Pharma and Nycomed Amersham (now GE). He has worked across many aspects of drug development and manufacturing during his career including analytical, production, quality and senior commercial roles across the world.
Dianne Sharp, managing director at SCM Pharma, said, “We are very pleased to welcome Paul to the SCM family as he is very experienced in our sector and will no doubt bring a huge amount to the table when it comes to the future strategy and direction for the business. His expertise in sterile filling, radiopharmaceuticals and his understanding of the FDA's quality regulatory requirements will be invaluable to have at board level and complements the existing skill set we have. Furthermore, his vast experience in dealing with Japanese and U.S. companies also aligns perfectly with our current commercial activities."